BRC491 |
Human breast invasive ductal carcinoma (IDC) tissue array, non overlapping with BRC711, 49 cases 49 cores
|
US Biomax |
|
142.00€ |
|
Pub |
BRC711 |
Human breast invasive ductal cancer tissue array, non overlapping with BRC491, 71 cases 72 cores
|
US Biomax |
|
142.00€ |
|
Pub |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax |
|
266.00€ |
|
Pub |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax |
|
99.00€ |
|
Pub |
BR1921 |
High density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
BR486 |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR1504 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243
|
US Biomax |
|
99.00€ |
|
Pub |
BR2085a |
High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c.
|
US Biomax |
|
456.00€ |
|
Pub |
BR809 |
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR8010 |
Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BS08011 |
Breast infiltrating ductal carcinoma tissue array, 22 cases 63 cores, replaced by BR727
|
US Biomax |
|
160.00€ |
|
Pub |
BR2085b |
High density (188 cases 208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast
|
US Biomax |
|
456.00€ |
|
Pub |
BC08016 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803
|
US Biomax |
|
160.00€ |
|
Pub |
NPC962 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC961, 96 cases 96 cores
|
US Biomax |
|
308.00€ |
|
Pub |
BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015
|
US Biomax |
|
231.00€ |
|
Pub |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax |
|
296.00€ |
|
Pub |
BRC961 |
Breast cancer array with normal and other non malignant breast tissues, non overlapping with BRC962, with AR ER PR Her 2(neu) IHC results, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456.00€ |
|
Pub |
BC08015 |
Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728
|
US Biomax |
|
160.00€ |
|
Pub |
BRM481 |
Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
NPC961 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC962, >50 cases 96 cores
|
US Biomax |
|
344.00€ |
|
Pub |
BRC1503 |
Breast cancer mid density tissue array, non overlapping with BRC1501 or BRC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BRC1502 |
Breast cancer mid density tissue array, non overlapping with either BRC1501 or BRC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR1001 |
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases 100 cores, replaced by BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
BR807 |
Medullary carcinoma of breast tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR1004 |
Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010
|
US Biomax |
|
314.00€ |
|
Pub |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95
|
US Biomax |
|
456.00€ |
|
Pub |
STC1502 |
Human stomach cancer mid density tissue array, non overlapping with STC1501 or STC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR245 |
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246
|
US Biomax |
|
88.00€ |
|
Pub |
BC08013 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014
|
US Biomax |
|
160.00€ |
|
Pub |
BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax |
|
189.00€ |
|
Pub |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212
|
US Biomax |
|
266.00€ |
|
Pub |
STC962 |
Human stomach cancer and normal tissue array, non overlapping with STC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BC08023 |
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BRC1501 |
Breast cancer mid density tissue array, non overlapping with either BRC1502 or BRC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR802b |
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases 80cores, replacing BR802
|
US Biomax |
|
266.00€ |
|
Pub |
BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021
|
US Biomax |
|
160.00€ |
|
Pub |
BR805 |
Breast infiltrating lobular carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
HER2 |
Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
114.00€ |
|
Pub |
BRC962 |
Breast cancer and normal tissue array, non overlapping with BRC961, with TNM data, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax |
|
429.00€ |
|
Pub |
BR483 |
Multiple breast cancer tissue array with normal tissues from autopsy, with TNM, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LVC1501 |
Liver cancer mid density tissue array, non overlapping with LVC1502 or LVC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR20818 |
Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SK802 |
Skin squamous cell carcinoma (SCC) tissue array, 80 cases 80 cores, no overlaps with SK801
|
US Biomax |
|
231.00€ |
|
Pub |
BS03013 |
Hepatocellular carcinoma tissue array, 22 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC03011 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010
|
US Biomax |
|
160.00€ |
|
Pub |
MNO381 |
Tissue profiling tissue array with 19 types of normal human tissues, 19 cases 38 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BR20832 |
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO802 |
Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801
|
US Biomax |
|
189.00€ |
|
Pub |
BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a
|
US Biomax |
|
88.00€ |
|
Pub |
FDA805 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
314.00€ |
|
Pub |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BR243 |
Breast cancer and adjacent normal tissue array, 6 cases 24 cores, replaced by BR243a
|
US Biomax |
|
88.00€ |
|
Pub |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502
|
US Biomax |
|
278.00€ |
|
Pub |
BN08013 |
Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801
|
US Biomax |
|
160.00€ |
|
Pub |
BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
CXC962 |
Cervical cancer and normal tissue array, non overlapping with CXC961, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
FDA997 |
FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998
|
US Biomax |
|
314.00€ |
|
Pub |
BN114 |
Multiple normal human organ tissue array, 48 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BRC2281 |
High density breast cancer tissue array, 228 cases 228 cores
|
US Biomax |
|
0.00€ |
|
Pub |
BR602 |
Breast tumor and normal tissue array, with TNM data, 25 cases 60 cores
|
US Biomax |
|
0.00€ |
|
Pub |
BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores
|
US Biomax |
|
278.00€ |
|
Pub |
LVC961 |
Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR20822 |
Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723
|
US Biomax |
|
160.00€ |
|
Pub |
FMC406 |
Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
TMA2081 |
High density (156 cases 208 cores) tissue array of normal colon, prostate and breast tissue
|
US Biomax |
|
456.00€ |
|
Pub |
BR8013 |
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC805 |
Lung large cell carcinoma and bronchioloalveolar carcinoma tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
MC962 |
Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores
|
US Biomax |
|
0.00€ |
|
Pub |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
REC1502 |
Rectal cancer mid density tissue array, non overlapping with REC1501 or REC1503, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013
|
US Biomax |
|
160.00€ |
|
Pub |
LV802 |
Liver carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with LV801
|
US Biomax |
|
189.00€ |
|
Pub |
BR1922 |
Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T084 |
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082
|
US Biomax |
|
88.00€ |
|
Pub |
BR20812 |
Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
KD811 |
Renal carcinoma and normal tissue array, with TNM, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC02021 |
Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR722 |
Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages
|
US Biomax |
|
231.00€ |
|
Pub |
GI961 |
GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC721 |
Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011
|
US Biomax |
|
231.00€ |
|
Pub |
BR20827 |
Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807
|
US Biomax |
|
160.00€ |
|
Pub |
TP242 |
Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC19015 |
Prostate carcinoma tissue array, 9 cases 27 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LYM1501 |
Lymphoma mid density tissue array, non overlapping with LYM1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR2088 |
Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011
|
US Biomax |
|
231.00€ |
|
Pub |
BC05022 |
Colon adenocarcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, no overlapping with BC05021
|
US Biomax |
|
231.00€ |
|
Pub |
LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
BC00116 |
Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LP803 |
Laryngeal squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
REC962 |
Rectal cancer and normal tissue array, non overlapping with REC961,48 cases 96 cores
|
US Biomax |
|
0.00€ |
|
Pub |
OVC961 |
Ovarian cancer and normal tissue array, non overlapping with OVC962, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
CR1001 |
Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR482 |
Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases 48 cores, with stage and grade info
|
US Biomax |
|
160.00€ |
|
Pub |
LC482 |
Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status
|
US Biomax |
|
160.00€ |
|
Pub |
BR20817 |
Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801
|
US Biomax |
|
321.00€ |
|
Pub |
BS03011 |
Hepatocellular carcinoma tissue array, 21 cases 63 cores, replaced by LV804
|
US Biomax |
|
160.00€ |
|
Pub |
KIC1502 |
Kidney cancer mid density tissue array, non overlapping with KIC1501, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011
|
US Biomax |
|
231.00€ |
|
Pub |
LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016
|
US Biomax |
|
231.00€ |
|
Pub |
BR20831 |
Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SM801 |
Small intestine carcinoma and normal tissue array, 77 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001
|
US Biomax |
|
231.00€ |
|
Pub |
BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
278.00€ |
|
Pub |
BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC21011 |
Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014
|
US Biomax |
|
231.00€ |
|
Pub |
BR242 |
Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores, replaced by BR244
|
US Biomax |
|
88.00€ |
|
Pub |
BR1502 |
Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503
|
US Biomax |
|
278.00€ |
|
Pub |
CVD481 |
Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807
|
US Biomax |
|
231.00€ |
|
Pub |
LUC1503 |
Lung cancer mid density tissue array, non overlapping with LUC1501 or LUC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
FDA995 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997
|
US Biomax |
|
278.00€ |
|
Pub |
KD802 |
Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LUC962 |
Lung cancer and normal tissue array, without overlapping with LUC961, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120
|
US Biomax |
|
278.00€ |
|
Pub |
LVC482 |
Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC481, 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BR20821 |
Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS04041 |
Lung squamous cell carcinoma (grade II) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SFD241 |
Human soft tissue disease tissue array, 24 cases 24 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BR8012 |
Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014
|
US Biomax |
|
231.00€ |
|
Pub |
CR601 |
Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602
|
US Biomax |
|
231.00€ |
|
Pub |
LC803 |
Lung carcinoma (multi tissue combined panel, 80 cases 80 cores) tissue array
|
US Biomax |
|
231.00€ |
|
Pub |
BC15012 |
Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR20836 |
Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2
|
US Biomax |
|
336.00€ |
|
Pub |
REC1501 |
Rectal cancer mid density tissue array, non overlapping with REC1502 or REC1503, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
BR808 |
Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018
|
US Biomax |
|
231.00€ |
|
Pub |
LC991 |
Lung squamous cell carcinoma (grade I III) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
OV951 |
Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores,
|
US Biomax |
|
456.00€ |
|
Pub |
COC1503 |
Colon cancer mid density tissue array, non overlapping with either COC1501 or COC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LV8013 |
Hepatocellular carcinoma tissue array, including TNM, pathology grade, HBV and HCV infection information, 40 cases 80 cores
|
US Biomax |
|
321.00€ |
|
Pub |
T083 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
UT803 |
Endometrioid carcinoma, adjacent and normal tissue array, with grade and stage information, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CXC961 |
Cervical cancer and normal tissue array, non overlapping with CXC962, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR20811 |
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR721 |
Breast cancer tissue array with self matching adjacent tissue and normal tissue, 24 cases 72 cores, no overlaps with other BR TMAs
|
US Biomax |
|
231.00€ |
|
Pub |
GI481 |
GI cancer (gastric, colon and rectal carcinoma) tissue array, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LC641 |
Non small cell lung carcinoma (NSCLC) tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
BC10021 |
Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR20826 |
Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PR804 |
Hyperplasia and carcinoma of prostate tissue array, 80 cases 80 cores, with grade and Gleason score information
|
US Biomax |
|
266.00€ |
|
Pub |
LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
TP241 |
Top 4 types of cancer (colon, breast, lung and prostate) tissue array, including TNM and pathology grade, 12 cases 24 cores
|
US Biomax |
|
99.00€ |
|
Pub |
BR8017 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
ST802 |
Stomach carcinoma (multi tissue combined panel) tissue array, 78 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC19014 |
Prostate carcinoma tissue array, 31 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR2087 |
Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC2081 |
Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information
|
US Biomax |
|
456.00€ |
|
Pub |
BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722
|
US Biomax |
|
231.00€ |
|
Pub |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
REC961 |
Rectum cancer and normal tissue array, non overlapping with REC962, 48 cases 96 cores
|
US Biomax |
|
0.00€ |
|
Pub |
STC1503 |
Stomach cancer mid density tissue array, non overlapping with STC1501 or STC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ES802 |
Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801
|
US Biomax |
|
231.00€ |
|
Pub |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811
|
US Biomax |
|
160.00€ |
|
Pub |
BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a
|
US Biomax |
|
88.00€ |
|
Pub |
COC962 |
Colon cancer and normal tissue array, non overlapping with COC961, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR481 |
Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LC481 |
Tissue array of lung carcinoma and matched adjacent tissue, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BC08014 |
Breast cancer (multiple types of breast cancer) tissue array, 63 cases 63 cores, replaced by BR8018
|
US Biomax |
|
160.00€ |
|
Pub |
BR20816 |
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
KIC1501 |
Kidney cancer mid density tissue array, non overlapping with KIC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
EMC1501 |
Endometrial cancer mid density tissue array, non overlapping with EMC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
NPC481 |
Nasopharyngeal carcinoma tissue array, 48 cases 49 cores
|
US Biomax |
|
189.00€ |
|
Pub |
PE801 |
Penile (penis) carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR726 |
Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
GIST802 |
Multiple organ stromal tumor tissue array (containing stomach, colon, rectum, small intestine, cardia, pancreas, retroperitoneum stroma and pelvic cavity), 80 cases 80 cores, no overlapping with GIST8
|
US Biomax |
|
296.00€ |
|
Pub |
BR20830 |
Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax |
|
266.00€ |
|
Pub |
LC1005 |
Lung carcinoma progression tissue array, 77 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC04022 |
Non small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
ST807 |
Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR241 |
Breast cancer test tissue array with self matched or unmatched normal adjacent tissues, 6 cases 24 cores.
|
US Biomax |
|
88.00€ |
|
Pub |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CVD231 |
Cardiovascular disease tissue array, non overlapping with CVD481, 23 cases 23 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BC01011 |
Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721
|
US Biomax |
|
160.00€ |
|
Pub |
LUC1502 |
Lung cancer mid density tissue array, non overlapping with LUC1501 or LUC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962
|
US Biomax |
|
314.00€ |
|
Pub |
TET481 |
Human testis cancer tissue array, 24 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ES961 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores
|
US Biomax |
|
336.00€ |
|
Pub |
BC08032 |
Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LVC481 |
Liver cancer and normal tissue array, non overlapping with LVC482, 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BR20820 |
Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS04031 |
Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724
|
US Biomax |
|
160.00€ |
|
Pub |
FMC405 |
Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
KIC962 |
Kidney cancer and normal tissue array, non overlapping with KIC961, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861
|
US Biomax |
|
266.00€ |
|
Pub |
BR8011 |
Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases 80 cores
|
US Biomax |
|
314.00€ |
|
Pub |
ES1501 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
LC802 |
Lung small cell carcinoma tissue array (40 cases 80 cores)
|
US Biomax |
|
266.00€ |
|
Pub |
BC12012 |
Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802
|
US Biomax |
|
231.00€ |
|
Pub |
BR20835 |
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011
|
US Biomax |
|
321.00€ |
|
Pub |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax |
|
231.00€ |
|
Pub |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
COC1502 |
Colon cancer mid density tissue array, non overlapping with either COC1501 or COC1503 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
BC06022 |
Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by RE722
|
US Biomax |
|
160.00€ |
|
Pub |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
|
US Biomax |
|
296.00€ |
|
Pub |
T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084
|
US Biomax |
|
88.00€ |
|
Pub |
UT802 |
Uteral cancer (multi types of uterine carcinomas and diseases) tissue array, 80 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995
|
US Biomax |
|
314.00€ |
|
Pub |
BC01071 |
Carcinoma of stomach, liver and rectum tissue array, 45 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LUC961 |
Lung cancer and normal tissue array, without overlapping with LUC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR20810 |
Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax |
|
81.00€ |
|
Pub |
BC02012 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR701 |
Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962
|
US Biomax |
|
231.00€ |
|
Pub |
BC09012 |
Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR20825 |
Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS04111 |
Lung small cell carcinoma tissue array, 33 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BC04012 |
Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BO244 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243
|
US Biomax |
|
100.00€ |
|
Pub |
BR8016 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LC808 |
Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011
|
US Biomax |
|
231.00€ |
|
Pub |
BC19013 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LY802 |
Lymph node metastatic squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001
|
US Biomax |
|
456.00€ |
|
Pub |
BC05012 |
Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores.
|
US Biomax |
|
231.00€ |
|
Pub |
BC34011 |
Head and neck squamous cell carcinoma tissue array, 24 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
COC961 |
Colon cancer and normal tissue array, non overlapping with COC962 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BC07014 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BR20815 |
Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS02041 |
Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
CO482 |
Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed
|
US Biomax |
|
742.00€ |
|
Pub |
NPC111 |
Nasopharyngeal carcinoma tissue array, 11 cases 11 cores
|
US Biomax |
|
106.00€ |
|
Pub |
BR725 |
Breast cancer, adjacent and adjacent normal tissue array, 68 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC11012 |
Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR2083 |
High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC1004 |
Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC04021 |
Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
BR2161 |
Breast cancer tissue array, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
456.00€ |
|
Pub |
OV804 |
Ovarian metastatic carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429.00€ |
|
Pub |
LV721 |
Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
KD482 |
Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LUC1501 |
Lung cancer mid density tissue array, non overlapping with LUC1502 or LUC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR962 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701
|
US Biomax |
|
231.00€ |
|
Pub |
BR480 |
Breast disease spectrum tissue array progression array, 48 cases 48 cores
|
US Biomax |
|
314.00€ |
|
Pub |
BR485 |
Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax |
|
397.00€ |
|
Pub |
BR2082 |
Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS04011 |
Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808
|
US Biomax |
|
160.00€ |
|
Pub |
KIC961 |
Kidney cancer and normal tissue array, non overlapping with KIC962, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BC03021 |
Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803
|
US Biomax |
|
231.00€ |
|
Pub |
BN501 |
Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013
|
US Biomax |
|
160.00€ |
|
Pub |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
EMC962 |
Endometrial cancer and normal tissue array, non overlapping with EMC961 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
MNO961 |
35 types of normal human tissue array, 90 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LC801 |
Lung carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR20834 |
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR082 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores
|
US Biomax |
|
112.00€ |
|
Pub |
IC00011 |
Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases 80 cores, replaced by IC00011b
|
US Biomax |
|
231.00€ |
|
Pub |
FDA806 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
380.00€ |
|
Pub |
BR806 |
Breast hyperplasia tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC951 |
Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
COC1501 |
Colon cancer mid density tissue array, non overlapping with either COC1502 or COC1503, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
BC06011 |
Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085
|
US Biomax |
|
88.00€ |
|
Pub |
LUC482 |
Lung cancer and normal tissue array, non overlapping with LUC481, 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084
|
US Biomax |
|
88.00€ |
|
Pub |
ESC1502 |
Esophagus cancer mid density tissue array, non overlapping with ESC1501, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
BR641 |
Breast cancer tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011
|
US Biomax |
|
231.00€ |
|
Pub |
BR20824 |
Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS04102 |
Large cell carcinoma of lung tissue array, 21 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BO243 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replaced by BO244
|
US Biomax |
|
88.00€ |
|
Pub |
FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a
|
US Biomax |
|
293.00€ |
|
Pub |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014
|
US Biomax |
|
231.00€ |
|
Pub |
CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC19012 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808
|
US Biomax |
|
231.00€ |
|
Pub |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a
|
US Biomax |
|
456.00€ |
|
Pub |
LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC050112 |
Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726
|
US Biomax |
|
231.00€ |
|
Pub |
BR1003 |
Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data
|
US Biomax |
|
266.00€ |
|
Pub |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BR812 |
Breast cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, with TNM data
|
US Biomax |
|
231.00€ |
|
Pub |
STC1501 |
Stomach cancer mid density tissue array, non overlapping with STC1502 or STC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR244 |
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245
|
US Biomax |
|
88.00€ |
|
Pub |
COC482 |
Colon cancer and normal tissue array, non overlapping with COC481 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax |
|
160.00€ |
|
Pub |
BR208 |
High density, multiple breast cancer (1 3 grade) and normal breast tissue array, 70 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC242 |
Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores
|
US Biomax |
|
321.00€ |
|
Pub |
LV809 |
Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014
|
US Biomax |
|
231.00€ |
|
Pub |
BR20814 |
Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723
|
US Biomax |
|
160.00€ |
|
Pub |
PR631 |
Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores
|
US Biomax |
|
266.00€ |
|
Pub |
LV1501 |
Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BRD181 |
Breast disease tissue array, 18 cases 18 cores
|
US Biomax |
|
118.00€ |
|
Pub |
ESC962 |
Esophagus cancer tissue array, non overlapping with ESC961, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR724 |
Breast cancer, adjacent and adjacent normal tissue array, 66 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR20829 |
Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC04016 |
Lung carcinoma tissue array, 72 cases 72 cores, replaced by LC726
|
US Biomax |
|
160.00€ |
|
Pub |
OM601 |
Metastatic carcinoma of epiploon tissue array, 60 cases 60 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002
|
US Biomax |
|
321.00€ |
|
Pub |
FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LV631 |
Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR1007 |
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
KD481 |
Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR961 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962
|
US Biomax |
|
0.00€ |
|
Pub |
STC961 |
Stomach cancer and normal tissue array, non overlapping with STC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR484 |
Breast cancer tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LVC1502 |
Liver cancer mid density tissue array, non overlapping with LVC1501 or LVC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR20819 |
Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BS03014 |
Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809
|
US Biomax |
|
160.00€ |
|
Pub |
BC03013 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723
|
US Biomax |
|
160.00€ |
|
Pub |
MC616 |
High density lung, breast, brain and colon cancer array, with stage, grade and normal tissue array, 308 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
BRN801 |
Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013
|
US Biomax |
|
231.00€ |
|
Pub |
EMC961 |
Endometrial cancer and normal tissue array, non overlapping with EMC962, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
FBN401 |
Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
278.00€ |
|
Pub |
BR801 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804
|
US Biomax |
|
231.00€ |
|
Pub |
MNO661 |
Normal organ tissue array of human, 66 cases 66 cores
|
US Biomax |
|
189.00€ |
|
Pub |
CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ES1201 |
Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202
|
US Biomax |
|
278.00€ |
|
Pub |
LC727 |
Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR20833 |
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR042a |
Breast cancer tissue array, including TNM and pathology grade, 4 cases 4 cores
|
US Biomax |
|
88.00€ |
|
Pub |
MS481 |
Human mesothelioma tissue array, 24 cases 48 cores
|
US Biomax |
|
314.00€ |
|
Pub |
LC2082 |
Multiple lung carcinoma and normal tissue array, 70 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti-
|
US Biomax |
|
296.00€ |
|
Pub |
KD486 |
Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LUC481 |
Lung cancer and normal tissue array, non overlapping with LUC482 , 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BN08111 |
Breast hyperplasia and normal tissue array, 10 cases 30 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BRC1021 |
Breast cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225.00€ |
|
Pub |
FDA998 |
FDA normal organ tissue array of human, 47 cases 99 cores, replaced by FDA999
|
US Biomax |
|
314.00€ |
|
Pub |
BRC481 |
Breast cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
ESC1501 |
Esophageal cancer mid density tissue array, non overlapping with ESC1502 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR6161 |
High density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115
|
US Biomax |
|
266.00€ |
|
Pub |
LVC962 |
Liver cancer and normal tissue array, non overlapping with LVC961, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BR20823 |
Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PR802 |
Prostate carcinoma tissue array, 80 cases 80 cores, no overlaps with PR801, replaced by PR8010
|
US Biomax |
|
231.00€ |
|
Pub |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
BO242 |
Human normal bone tissue array, 12 cases 24 cores, replaced by BO243
|
US Biomax |
|
100.00€ |
|
Pub |
BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012
|
US Biomax |
|
231.00€ |
|
Pub |
ES2001 |
Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores
|
US Biomax |
|
516.00€ |
|
Pub |
LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013
|
US Biomax |
|
231.00€ |
|
Pub |
LC1921 |
High density non small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC05011 |
Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804
|
US Biomax |
|
231.00€ |
|
Pub |
FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2
|
US Biomax |
|
277.00€ |
|
Pub |
BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores
|
US Biomax |
|
278.00€ |
|
Pub |
REC1503 |
Rectum cancer mid density tissue array, non overlapping with REC1501 or REC1502, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
BR811 |
Breast cancer tissue array with normal tissues from autopsy, 80 cases 80 cores, with grade and stage data
|
US Biomax |
|
231.00€ |
|
Pub |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
COC481 |
Colon cancer and normal tissue array, non overlapping with COC482 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BC07012 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015
|
US Biomax |
|
160.00€ |
|
Pub |
BR2001 |
Breast cancer high density tissue array, 196 cases 200 cores, replaced by BR2086
|
US Biomax |
|
456.00€ |
|
Pub |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088
|
US Biomax |
|
88.00€ |
|
Pub |
OVC962 |
Ovarian cancer and normal tissue array, non overlapping with OVC961, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores
|
US Biomax |
|
558.00€ |
|
Pub |
BR20813 |
Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SK483 |
Multiple skin squamous cell carcinoma tissue array with normal tissues control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085
|
US Biomax |
|
88.00€ |
|
Pub |
BS02021 |
Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
KD951 |
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC02022 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
ESC961 |
Esophageal cancer tissue array, non overlapping with ESC962, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
ART661 |
Rat(Wistar strain) normal tissue array, covering all major organs, non overlapping with ART662, 22 cases 66 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR723 |
Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases 72 cores
|
US Biomax |
|
314.00€ |
|
Pub |
BC11011 |
Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BR20828 |
Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC04015 |
Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
CO1002 |
Colon and rectum carcinoma and normal tissue array, 73 cases 100 cores, replaced by CO1002b
|
US Biomax |
|
278.00€ |
|
Pub |
BR802 |
Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases 80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b
|
US Biomax |
|
231.00€ |
|
Pub |
BC19017 |
Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809
|
US Biomax |
|
160.00€ |
|
Pub |
LYM1502 |
Lymphoma mid density tissue array, non overlapping with LYM1501, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BR2089 |
Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO812 |
Colon carcinoma and normal tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR1006 |
Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
114.00€ |
|
Pub |
KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR247 |
Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide
|
US Biomax |
|
189.00€ |
|
Pub |
ES809 |
Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
SO809 |
Sarcoma tissue array of soft tissue (adipose, fibrous tissue, smooth muscles and striated muscles), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T214 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ME482 |
Malignant melanoma array with matched normal tissue control, stage and TNM, 48 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
CR2081 |
High density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LC483 |
Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T095 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
OV20814 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084
|
US Biomax |
|
558.00€ |
|
Pub |
PR751 |
Prostate cancer, PIN (prostatic intraepithelial neoplasia) and hyperplasia tissue array, 75 cases 75 cores, with grade and Gleason's Score data
|
US Biomax |
|
266.00€ |
|
Pub |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
FMC402 |
Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores
|
US Biomax |
|
91.00€ |
|
Pub |
KIC241 |
Kidney cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
166.00€ |
|
Pub |
LV208 |
Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases 208 cores) tissue microarray, with stage and grade info
|
US Biomax |
|
456.00€ |
|
Pub |
BN482 |
Normal human tissue microarray from 12 organs from autopsy, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
MC601 |
Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BRM961 |
Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea 96 cores
|
US Biomax |
|
314.00€ |
|
Pub |
ST485 |
Stomach cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
T009 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
EMC241 |
Endometrium cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
189.00€ |
|
Pub |
RE241 |
Rectal cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BL482 |
Bladder cancer tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
ST723 |
Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042
|
US Biomax |
|
231.00€ |
|
Pub |
T291a |
Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin
|
US Biomax |
|
114.00€ |
|
Pub |
PA241b |
Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241
|
US Biomax |
|
99.00€ |
|
Pub |
CR483 |
Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with TNM data
|
US Biomax |
|
160.00€ |
|
Pub |
ES1002 |
Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
GL1002 |
Brain tumor and normal tissue array, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BC111110 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LY2084 |
Lymphoma tumor survey tissue array (4 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
SM802 |
Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T141a |
Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
OV483 |
Multiple ovarian cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info
|
US Biomax |
|
160.00€ |
|
Pub |
BS06041 |
Rectum adenocarcinoma (grade III) tissue array, 21 cases 63 cores, replaced by RE724
|
US Biomax |
|
160.00€ |
|
Pub |
PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
FMS152 |
Liver of multiple species frozen tissue array, 14 cases 15 cores
|
US Biomax |
|
293.00€ |
|
Pub |
LC1007 |
Lung tuberculosis tissue array with normal tissue, 48 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV242 |
Multiple Liver cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
MC807 |
Multiple types of cancer tissue array, with stage and TNM information, 40 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
T043 |
Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
TR041 |
Rat normal lung test tissue array, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
OR2081 |
Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO1501 |
Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
KD2082 |
High density kidney cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LM802 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
RE812 |
Rectal cancer tissue array with normal tissue from autopsy, 40 cases 80 cores, with grade and stage data
|
US Biomax |
|
231.00€ |
|
Pub |
ST810 |
Stomach cancer with matched lymph node metastasis tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T392 |
Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391
|
US Biomax |
|
88.00€ |
|
Pub |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ES483 |
Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
GL803 |
Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases 80 cores, replacing BS17015
|
US Biomax |
|
266.00€ |
|
Pub |
LC816 |
Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC21014 |
Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011
|
US Biomax |
|
231.00€ |
|
Pub |
SO2084 |
Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T176 |
Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
OV807 |
Ovarian cancer tissue array with normal tissue, grade and TNM data, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CO992 |
Colorectal (colon and rectum) cancer with matched lymph node metastasis and normal adjacent tissue array, 43 cases 99 cores
|
US Biomax |
|
266.00€ |
|
Pub |
GA801 |
Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
123.00€ |
|
Pub |
LC20816 |
Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011
|
US Biomax |
|
231.00€ |
|
Pub |
MCN601 |
Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602
|
US Biomax |
|
231.00€ |
|
Pub |
T073 |
Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
UT501 |
Endometrioid adenocarcinoma and normal tissue array with TNM and grade, 50 cases 50 cores
|
US Biomax |
|
160.00€ |
|
Pub |
HN483 |
Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482
|
US Biomax |
|
160.00€ |
|
Pub |
OS804 |
Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011
|
US Biomax |
|
266.00€ |
|
Pub |
PR2085a |
High density (114 cases 208 cores) prostate adenocarcinoma (I 4 grade) and normal prostate (from autopsy and cancer adjacent) tissue array
|
US Biomax |
|
456.00€ |
|
Pub |
CO2087 |
Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CXC1021 |
Cervix cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225.00€ |
|
Pub |
KD485 |
Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BC01022 |
Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LUC2281 |
High density lung cancer tissue array, 228 cases 228 cores
|
US Biomax |
|
403.00€ |
|
Pub |
MC243 |
Multiple cancer (3 types) tissue array, 24 cases 24 cores, with grade and stage data
|
US Biomax |
|
100.00€ |
|
Pub |
ST1502 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
TH241 |
Thyroid cancer tissue array with self matching normal adjacent tissues, 10 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
NGL481 |
Nervous system glioma tissue array, 24 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
KD803 |
Normal kidney tissue array, replacing BN07012, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC01081 |
Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases 616 cores
|
US Biomax |
|
456.00€ |
|
Pub |